Michael Gelband’s CATALENT, INC. CTLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-199,965
Closed -$12.1M 2187
2024
Q3
$12.1M Buy
199,965
+96,418
+93% +$5.71M 0.07% 207
2024
Q2
$5.82M Buy
103,547
+73,755
+248% +$4.11M 0.04% 362
2024
Q1
$1.68M Buy
+29,792
New +$1.61M 0.01% 772
2023
Q4
Sell
-15,251
Closed -$694K 2155
2023
Q3
$694K Buy
+15,251
New +$713K 0.01% 1115
2023
Q2
Sell
-6,373
Closed -$419K 2328
2023
Q1
$419K Buy
6,373
+1,726
+37% +$107K ﹤0.01% 1380
2022
Q4
$209K Sell
4,647
-59,322
-93% -$3.22M ﹤0.01% 1449
2022
Q3
$4.63M Buy
+63,969
New +$6.35M 0.06% 430
2022
Q1
Sell
-15,649
Closed -$2M 2763
2021
Q4
$2M Buy
+15,649
New +$2.01M 0.02% 761
2021
Q3
Sell
-3,692
Closed -$399K 2761
2021
Q2
$399K Sell
3,692
-7,190
-66% -$771K ﹤0.01% 1572
2021
Q1
$1.15M Buy
+10,882
New +$1.21M 0.02% 833
2020
Q2
Sell
-9,898
Closed -$514K 2088
2020
Q1
$514K Buy
+9,898
New +$540K 0.03% 477
2019
Q4
Sell
-5,000
Closed -$238K 1968
2019
Q3
$238K Buy
+5,000
New +$269K 0.01% 1030
2019
Q2
Sell
-29,045
Closed -$1.18M 1379
2019
Q1
$1.18M Buy
+29,045
New +$1.13M 0.09% 164

Other funds holding CTLT

Michael Gelband's CTLT Position: Q4 2024 in Review

Michael Gelband sold out of CATALENT, INC. (CTLT) in Q4 2024, closing a stake of 199,965 shares — an estimated $12.1M sold.

Michael Gelband first reported a position in CTLT in Q1 2019 and held it in 13 quarters. The position peaked at $12.1M in Q3 2024. 6 funds tracked by Wall St. Rank hold CTLT as of Q4 2024.

  • Michael Gelband reported no remaining CATALENT, INC. position as of Q4 2024 after selling out during the quarter.
  • Michael Gelband sold 199,965 CATALENT, INC. shares in Q4 2024, an estimated $12.1M.
  • Michael Gelband first reported a position in CATALENT, INC. in Q1 2019 and held it in 13 quarters.
  • Michael Gelband's CATALENT, INC. position peaked at $12.1M in Q3 2024.
  • 6 funds tracked by Wall St. Rank held CATALENT, INC. as of Q4 2024.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.